Sowell Financial Services
KNSA icon

Sowell Financial Services’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Sowell Financial Services’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.04M Buy
+40,735
New +$3M 0.1% 221
2021
Q2 		– Sell
-226
Closed -$3K – 1703
2021
Q1 		$3K Buy
+226
New +$4.62K ﹤0.01% 2740

Other funds holding KNSA

Essex Investment Management
Essex Investment Management Boston, Massachusetts $675M AUM 61.81% 1-Year Est. Return
Linden Thomas Advisory Services
Linden Thomas Advisory Services Charlotte, North Carolina $1.26B AUM 37.95% 1-Year Est. Return
Mutual of America Capital Management
Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return
TGY2IT
Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $530M AUM 95.29% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Toth Financial Advisory
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
Sigma Planning Corp
Sigma Planning Corp Ann Arbor, Michigan $3.88B AUM 23.38% 1-Year Est. Return
Juncture Wealth Strategies
Juncture Wealth Strategies Scottsdale, Arizona $390M AUM 19.15% 1-Year Est. Return
TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return
AMI Asset Management
AMI Asset Management Los Angeles, California $1.74B AUM 24.77% 1-Year Est. Return

Sowell Financial Services's KNSA Position: Q3 2026 in Review

Sowell Financial Services opened a new position in Kiniksa Pharmaceuticals (KNSA) in Q3 2026: 40,735 shares worth $3.04M. The stake represents 0.1% of the portfolio and ranks #221 among its holdings. This is a return to the name: Sowell Financial Services previously reported a position in KNSA as recently as Q1 2021.

Sowell Financial Services first reported a position in KNSA in Q1 2021 and has held it in 2 quarters since. 40 funds tracked by Wall St. Rank hold KNSA as of Q3 2026.

  • Sowell Financial Services held 40,735 shares of Kiniksa Pharmaceuticals worth $3.04M as of Q3 2026.
  • Kiniksa Pharmaceuticals was a new Sowell Financial Services position in Q3 2026.
  • Kiniksa Pharmaceuticals made up 0.1% of Sowell Financial Services's portfolio in Q3 2026, its #221 holding.
  • Sowell Financial Services first reported a position in Kiniksa Pharmaceuticals in Q1 2021 and has held it in 2 quarters since.
  • 40 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q3 2026.

Based on Sowell Financial Services's 13F filing for Q3 2026, filed 20 Oct 2026.